May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Roberto Scicali, Antonino Di Pino, Salvatore Piro, Agata Maria Rabuazzo, Francesco Purrello
Topics & Concepts
Familial hypercholesterolemiaPCSK9Coronavirus disease 2019 (COVID-19)MedicineVirology2019-20 coronavirus outbreakLdl cholesterolSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacologyCholesterolInternal medicineLDL receptorLipoproteinDiseaseOutbreakInfectious disease (medical specialty)Lipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismVitamin C and Antioxidants Research